NHS National Generic Pharmaceuticals Interim 2 2020
A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Source
- OJEU
- Type
- Framework (Supply)
- Duration
- 1 year (est.)
- Value
- £49M
- Sector
- HEALTH
- Published
- 08 Feb 2021
- Delivery
- 01 Feb 2021 to 28 Feb 2022 (est.)
- Deadline
- n/a
Concepts
Location
Runcorn
Geochart for 2 buyers and 67 suppliers
2 buyers
51 suppliers
- Abbvie Maidenhead
- Accord Barnstaple
- Altan Pharma Ware
- Aspire Pharma Petersfield
- Baxter Healthcare Thetford
- Drugsrus Harrow
- Fresenius Kabi Runcorn
- Cipla Eu London
- Consilient Health Richmond
- Glaxosmithkline Brentford
- Martindale Pharma High Wycombe
- Kent Pharma Ashford
- Medac Pharma Stirling
- Ranbaxy Hayes
- Milpharm South Ruislip
- Teva Castleford
- Mercury Pharmaceuticals London
- Mylan Hatfield
- Panpharma Liverpool
- Selective Supplies Haywards Heath
- Tillomed Laboratories Luton
- Pfizer Tadworth
- Sandoz Camberley
- Laboratorio Reig Jofre Bideford
- Thornton & Ross Huddersfield
- Zentiva Pharma Guildford
- Amarox Harrow
- Brown & Burk Uxbridge
- Crescent Pharma Basingstoke
- Lexon Redditch
- Aventis Pharma Reading
- CST Pharma Walsall
- Focus Pharmaceuticals London
- Bristol Laboratories Berkhamstead
- Essential Healthcare Brentwood
- Glenmark Pharmaceuticals Europe Watford
- Healthcare Pharma Haslemere
- Hfa Healthcare Products Hampton in Arden
- Syri South Ruislip
- Waymade Basildon
- Macleods Pharma Billingham
- Manx Healthcare Warwick
- Necessity Supplies Northolt
- Medley Pharma Bootle
- Medreich Feltham
- Morningside Pharmaeuticals Loughborough
- Qdem Pharmaceuticals Cambridge
- Rivopharm London
- Sciecure Pharma Guildford
- Upjohn Tadworth
- Wockhardt Wrexham
Description
Hospital only products — All regions: 1 February 2021 to 31 January 2022 Orals (plus non-parenterals) – All regions: 1 March 2021 to 28 February 2022 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months.
Lot Division
| 1 | Interim 2 2020 — Hospital Only Products — All Regions 1 February 2021 to 31 January 2022 NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months Potential periods of call-offs under the framework agreement: Hospital only products — … All regions: 1 March 2021 to 28 February 2022. |
| 2 | Interim 2 2020 — Orals (+ non-parenterals) — All regions 1 March 2021 to 28 February 2022 NHS National Generic Pharmaceuticals Interim 2 2020 Offer reference number: CM/PHG/20/5619 Period of framework agreement: 12 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 36 months. The total maximum duration of the framework agreement to be no more than 48 months OJEU Reference number: [insert OJEU Reference number] Potential periods of call-offs under the framework agreement: Hospital only products - … All regions: 1 March 2021 to 28 February 2022. |
Award Detail
| 1 | Abbvie (Maidenhead)
|
| 2 | Accord (Barnstaple)
|
| 3 | Altan Pharma (Ware)
|
| 4 | Aspire Pharma (Petersfield)
|
| 5 | Baxter Healthcare (Thetford)
|
| 6 | Drugsrus (Harrow)
|
| 7 | Fresenius Kabi (Runcorn)
|
| 8 | Cipla Eu (London)
|
| 9 | Consilient Health (Richmond)
|
| 10 | Glaxosmithkline (Brentford)
|
| 11 | Martindale Pharma (High Wycombe)
|
| 12 | Kent Pharma (Ashford)
|
| 13 | Medac Pharma (Stirling)
|
| 14 | Ranbaxy (Hayes)
|
| 15 | Milpharm (South Ruislip)
|
| 16 | Teva (Castleford)
|
| 17 | Mercury Pharmaceuticals (London)
|
| 18 | Mylan (Hatfield)
|
| 19 | Panpharma (Liverpool)
|
| 20 | Selective Supplies (Haywards Heath)
|
| 21 | Tillomed Laboratories (Luton)
|
| 22 | Pfizer (Tadworth)
|
| 23 | Sandoz (Camberley)
|
| 24 | Laboratorio Reig Jofre (Bideford)
|
| 25 | Thornton & Ross (Huddersfield)
|
| 26 | Zentiva Pharma (Guildford)
|
| 27 | Accord (Barnstaple)
|
| 28 | Amarox (Harrow)
|
| 29 | Brown & Burk (Uxbridge)
|
| 30 | Crescent Pharma (Basingstoke)
|
| 31 | Aspire Pharma (Petersfield)
|
| 32 | Kent Pharma (Ashford)
|
| 33 | Lexon (Redditch)
|
| 34 | Martindale Pharma (High Wycombe)
|
| 35 | Aventis Pharma (Reading)
|
| 36 | CST Pharma (Walsall)
|
| 37 | Focus Pharmaceuticals (London)
|
| 38 | Bristol Laboratories (Berkhamstead)
|
| 39 | Essential Healthcare (Brentwood)
|
| 40 | Cipla Eu (London)
|
| 41 | Drugsrus (Harrow)
|
| 42 | Glenmark Pharmaceuticals Europe (Watford)
|
| 43 | Healthcare Pharma (Haslemere)
|
| 44 | Hfa Healthcare Products (Hampton in Arden)
|
| 45 | Mercury Pharmaceuticals (London)
|
| 46 | Syri (South Ruislip)
|
| 47 | Waymade (Basildon)
|
| 48 | Macleods Pharma (Billingham)
|
| 49 | Manx Healthcare (Warwick)
|
| 50 | Necessity Supplies (Northolt)
|
| 51 | Zentiva Pharma (Guildford)
|
| 52 | Medley Pharma (Bootle)
|
| 53 | Medreich (Feltham)
|
| 54 | Milpharm (South Ruislip)
|
| 55 | Morningside Pharmaeuticals (Loughborough)
|
| 56 | Ranbaxy (Hayes)
|
| 57 | Mylan (Hatfield)
|
| 58 | Qdem Pharmaceuticals (Cambridge)
|
| 59 | Rivopharm (London)
|
| 60 | Sciecure Pharma (Guildford)
|
| 61 | Selective Supplies (Haywards Heath)
|
| 62 | Pfizer (Tadworth)
|
| 63 | Teva (Castleford)
|
| 64 | Tillomed Laboratories (Luton)
|
| 65 | Thornton & Ross (Huddersfield)
|
| 66 | Upjohn (Tadworth)
|
| 67 | Wockhardt (Wrexham)
|
Award Criteria
| PRICE | _ |
CPV Codes
- 33690000 - Various medicinal products
Indicators
- Options are available.
- Award on basis of price.
Reference
- OJEU 065599-2021